Stifel Financial’s Immunomedics Inc IMMU Stock Holding History

Stifel Financial’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-63,631	Closed	-$5.41M	–	3172
2020 Q3	$5.41M	Buy	63,631 +1,742	+3%	+$88.1K	0.01%	738
2020 Q2	$2.19M	Sell	61,889 -123	-0.2%	-$3.6K	0.01%	1106
2020 Q1	$832K	Sell	62,012 -79,848	-56%	-$1.34M	﹤0.01%	1549
2019 Q4	$3M	Buy	141,860 +93,798	+195%	+$1.65M	0.01%	1103
2019 Q3	$637K	Buy	48,062 +1,453	+3%	+$21.4K	﹤0.01%	2030
2019 Q2	$649K	Buy	46,609 +4,224	+10%	+$63.6K	﹤0.01%	2058
2019 Q1	$814K	Buy	+42,385	New	+$683K	﹤0.01%	1781
2015 Q4	–	Sell	-17,000	Closed	-$29K	–	2417
2015 Q3	$29K	Buy	+17,000	New	+$43.4K	﹤0.01%	2199

Stifel Financial's IMMU Position: Q4 2020 in Review

Stifel Financial sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 63,631 shares — an estimated $5.41M sold.

Stifel Financial first reported a position in IMMU in Q3 2015 and held it in 8 quarters. The position peaked at $5.41M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Stifel Financial reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Stifel Financial sold 63,631 Immunomedics Inc shares in Q4 2020, an estimated $5.41M.
Stifel Financial first reported a position in Immunomedics Inc in Q3 2015 and held it in 8 quarters.
Stifel Financial's Immunomedics Inc position peaked at $5.41M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Stifel Financial's 13F filing for Q4 2020, filed 12 Feb 2021.